CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 30 target
Drug / intervention
Clinical assessment, blood samples, bone marrow and bone biopsyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05483738
NCT05483738N/AActiveOn TrackUpdated 8mo ago

The Impact of Mitochondrial Dysfunction on Human Bone Cell Metabolism and Remodelling

Aalborg University Hospital·interventional·Posted Aug 2, 2022·Updated Oct 2, 2025

In Brief

A clinical study evaluating Clinical assessment, blood samples, bone marrow and bone biopsy for Mitochondrial Diseases and Bone Remodeling Disorder. Active but no longer recruiting, targeting 30 participants across 1 site.

Detailed Summary

Cell and mice studies suggest mitochondrial dysfunction may cause altered bone structure. Hypothesis: Decreased mitochondrial energy production affects bone cell development and activity negatively. Comparing humans with the mitochondrial DNA variant, m.3243A\>G, pathogenic variants in POLG or TWNK genes to healthy controls, the aim is to evaluate the effect of mitochondrial dysfunction on: 1: bone-cell development and -activity in bone marrow stem cells and blood. 2: bone cell metabolism including glucose consumption. 3: bone structure assessed by electron microscopy and μCT scans of bone biopsies.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesDenmark

Timeline

N/AActive
20202021202220232024202520262027
First PostedAug 2, 2022
Enrollment StartFeb 1, 2020
Primary CompletionAug 1, 2026
Study CompletionDec 1, 2026
TodayJul 2, 2026
Enrollment to primary: 6.5 yearsPosted 3.9 years agoPrimary completion in 29 days

Interventions

Clinical assessment, blood samples, bone marrow and bone biopsyother

Assessment of blood samples, bone marrow and bone biopsy